Goldberg Andrew D.
CIK 0001827722
CEO and PresidentDirector
Filings
8
Latest Apr 21, 2026
Issuers covered
2
Showing
8 of 8
Page 1
Track record
1 of 1 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 1 | 100% | +18.7% | +18.7% | +18.7% | +18.7% |
| 90 days | 1 | 100% | +54.5% | +54.5% | +54.5% | +54.5% |
| 180 days | 1 | 100% | +71.9% | +71.9% | +71.9% | +71.9% |
| 365 days | 1 | 100% | +171.5% | +171.5% | +171.5% | +171.5% |
Issuers
Companies where Goldberg Andrew D. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| TARS | Tarsus Pharmaceuticals, Inc. | 7 | Jun 16, 2025 |
| ACHV | Achieve Life Sciences, Inc. | 1 | Apr 21, 2026 |
All filings
8 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|